Skip to main content

Take our TMF Risk Score Survey today!

Trial Interactive News & Press

Monday, March 18, 2019 | 11:18 AM

Clinipace Selects TransPerfect's Trial Interactive

Clinipace Selects TransPerfect's Trial Interactive eFeasibility and eTMF Solutions to Support Future Studies

NEW YORK, March 18, 2019TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that Clinipace has selected TransPerfect’s Trial Interactive eFeasibility and eTMF solutions as part of their ongoing initiative to further cultivate a flexible and responsive infrastructure to support clinical research.

Clinipace is a global, full-service contract research organization (CRO) providing personalized services and solutions, local regulatory expertise, and therapeutic leadership across major therapeutic areas that include oncology, gastroenterology, nephrology, and urology. Investments in innovative technologies enable Clinipace to provide industry-leading tools to staff, site personnel, and clients with maximum transparency and visibility.

The Trial Interactive eClinical platform was designed by clinical professionals, for clinical professionals. It is used by pharmaceutical, biotechnology, and CRO companies to streamline product development life cycles in a secure, 21 CFR Part 11-compliant environment. By offering a fully integrated suite of solutions, Trial Interactive improves speed and quality across site identification and selection, personnel training, study start-up and site activation, eTMF management, and closeout. The Trial Interactive platform delivers nuanced, clinical research-focused products that simplify tasks, oversight, compliance, and audits/inspections.

“We reviewed many solutions, and Trial Interactive offered the intuitive interface, transparency, hosting, support, and validation that was essential to our decision,” said Michael Townley, CIO, Clinipace. “The additional willingness to work with our other vendors and integration partners made Trial Interactive an obvious choice.”

“We are proud to have been selected by Clinipace to add our eFeasibility and eTMF solutions to their technology stack,” said Phil Shawe, President and CEO of TransPerfect. “The studies they conduct are essential to bringing important treatments to market and improving patient lives.”

About Trial Interactive
TransPerfect’s Trial Interactive is an industry leader in practical eClinical innovation that simplifies and automates clinical processes for sponsors, CROs, and sites around the world. The 21 CFR Part 11 compliant unified platform delivers an author-to-archive collaboration experience with solutions for clinical document management, site selection, site activation, e-learning, compliance training, quality, and more with seamless solution interoperability and indexing to the eTMF. Trial Interactive is consistently selected by clinical professionals for providing the most comprehensive yet intuitive experience with the most complete offering of technology and expert TMF services. Trial Interactive helps study teams streamline their operations by cutting unnecessary expenses, expediting timelines, reducing compliance risks, and improving operational excellence. For more information on Trial Interactive, please contact or +1 212.400.8848, or visit our website here.

About TransPerfect
TransPerfect is the world’s largest provider of language and technology solutions for global business. From offices in over 100 cities on six continents, TransPerfect offers a full range of services in 170+ languages to clients worldwide. More than 5,000 global organizations employ TransPerfect’s GlobalLink® Product Suite to simplify management of multilingual content. With an unparalleled commitment to quality and client service, TransPerfect is fully ISO 9001 and ISO 17100 certified. TransPerfect has global headquarters in New York, with regional headquarters in London and Hong Kong. For more information, please visit our website at

Back to News